Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 126 Pages
Report ld: 6502352
Request Sample
Customized Report
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Valacyclovir API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Valaciclovir(CAS:124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Valacyclovir API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Valacyclovir API. The Valacyclovir API market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Valacyclovir API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Valacyclovir API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Valacyclovir API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Valacyclovir API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Valacyclovir API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Valacyclovir API Market Overview
1.1 Product Definition
1.2 Valacyclovir API by Type
1.2.1 Global Valacyclovir API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Valacyclovir API by Application
1.3.1 Global Valacyclovir API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Valacyclovir API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Valacyclovir API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Valacyclovir API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Valacyclovir API Production Market Share by Manufacturers (2021–2026)
2.2 Global Valacyclovir API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Valacyclovir API, Industry Ranking, 2024 vs 2025
2.4 Global Valacyclovir API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Valacyclovir API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Valacyclovir API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Valacyclovir API, Product Offerings and Applications
2.8 Global Key Manufacturers of Valacyclovir API, Date of Entry into the Industry
2.9 Valacyclovir API Market Competitive Situation and Trends
2.9.1 Valacyclovir API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Valacyclovir API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Valacyclovir API Production by Region
3.1 Global Valacyclovir API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Valacyclovir API Production Value by Region (2021–2032)
3.2.1 Global Valacyclovir API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Valacyclovir API by Region (2027–2032)
3.3 Global Valacyclovir API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Valacyclovir API Production Volume by Region (2021–2032)
3.4.1 Global Valacyclovir API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Valacyclovir API by Region (2027–2032)
3.5 Global Valacyclovir API Market Price Analysis by Region (2021–2032)
3.6 Global Valacyclovir API Production, Value, and Year-over-Year Growth
3.6.1 North America Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Australia Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
3.6.5 Israel Valacyclovir API Production Value Estimates and Forecasts (2021–2032)
4 Valacyclovir API Consumption by Region
4.1 Global Valacyclovir API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Valacyclovir API Consumption by Region (2021–2032)
4.2.1 Global Valacyclovir API Consumption by Region (2021–2026)
4.2.2 Global Valacyclovir API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Valacyclovir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Valacyclovir API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Valacyclovir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Valacyclovir API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Valacyclovir API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Valacyclovir API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Valacyclovir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Valacyclovir API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Valacyclovir API Production by Type (2021–2032)
5.1.1 Global Valacyclovir API Production by Type (2021–2026)
5.1.2 Global Valacyclovir API Production by Type (2027–2032)
5.1.3 Global Valacyclovir API Production Market Share by Type (2021–2032)
5.2 Global Valacyclovir API Production Value by Type (2021–2032)
5.2.1 Global Valacyclovir API Production Value by Type (2021–2026)
5.2.2 Global Valacyclovir API Production Value by Type (2027–2032)
5.2.3 Global Valacyclovir API Production Value Market Share by Type (2021–2032)
5.3 Global Valacyclovir API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Valacyclovir API Production by Application (2021–2032)
6.1.1 Global Valacyclovir API Production by Application (2021–2026)
6.1.2 Global Valacyclovir API Production by Application (2027–2032)
6.1.3 Global Valacyclovir API Production Market Share by Application (2021–2032)
6.2 Global Valacyclovir API Production Value by Application (2021–2032)
6.2.1 Global Valacyclovir API Production Value by Application (2021–2026)
6.2.2 Global Valacyclovir API Production Value by Application (2027–2032)
6.2.3 Global Valacyclovir API Production Value Market Share by Application (2021–2032)
6.3 Global Valacyclovir API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Valacyclovir API Company Information
7.1.2 Mylan Valacyclovir API Product Portfolio
7.1.3 Mylan Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Valacyclovir API Company Information
7.2.2 NEWEDGE Overseas Valacyclovir API Product Portfolio
7.2.3 NEWEDGE Overseas Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 NEWEDGE Overseas Main Business and Markets Served
7.2.5 NEWEDGE Overseas Recent Developments/Updates
7.3 Aurore Life Sciences
7.3.1 Aurore Life Sciences Valacyclovir API Company Information
7.3.2 Aurore Life Sciences Valacyclovir API Product Portfolio
7.3.3 Aurore Life Sciences Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Aurore Life Sciences Main Business and Markets Served
7.3.5 Aurore Life Sciences Recent Developments/Updates
7.4 Arch Pharmalabs
7.4.1 Arch Pharmalabs Valacyclovir API Company Information
7.4.2 Arch Pharmalabs Valacyclovir API Product Portfolio
7.4.3 Arch Pharmalabs Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Arch Pharmalabs Main Business and Markets Served
7.4.5 Arch Pharmalabs Recent Developments/Updates
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Valacyclovir API Company Information
7.5.2 SMS Pharmaceuticals Valacyclovir API Product Portfolio
7.5.3 SMS Pharmaceuticals Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 SMS Pharmaceuticals Main Business and Markets Served
7.5.5 SMS Pharmaceuticals Recent Developments/Updates
7.6 Exemed PharmaceuticalsFDAWHO-GMP
7.6.1 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Company Information
7.6.2 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Portfolio
7.6.3 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Exemed PharmaceuticalsFDAWHO-GMP Main Business and Markets Served
7.6.5 Exemed PharmaceuticalsFDAWHO-GMP Recent Developments/Updates
7.7 Aurobindo Pharma LimitedFDAEDQMWHO-GMP
7.7.1 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Company Information
7.7.2 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Portfolio
7.7.3 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Main Business and Markets Served
7.7.5 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Developments/Updates
7.8 Piramal Pharma Solutions
7.8.1 Piramal Pharma Solutions Valacyclovir API Company Information
7.8.2 Piramal Pharma Solutions Valacyclovir API Product Portfolio
7.8.3 Piramal Pharma Solutions Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Piramal Pharma Solutions Main Business and Markets Served
7.8.5 Piramal Pharma Solutions Recent Developments/Updates
7.9 Rajasthan Antibiotics
7.9.1 Rajasthan Antibiotics Valacyclovir API Company Information
7.9.2 Rajasthan Antibiotics Valacyclovir API Product Portfolio
7.9.3 Rajasthan Antibiotics Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Rajasthan Antibiotics Main Business and Markets Served
7.9.5 Rajasthan Antibiotics Recent Developments/Updates
7.10 Vital Laboratories Private Limited
7.10.1 Vital Laboratories Private Limited Valacyclovir API Company Information
7.10.2 Vital Laboratories Private Limited Valacyclovir API Product Portfolio
7.10.3 Vital Laboratories Private Limited Valacyclovir API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Vital Laboratories Private Limited Main Business and Markets Served
7.10.5 Vital Laboratories Private Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Valacyclovir API Industry Chain Analysis
8.2 Valacyclovir API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Valacyclovir API Production Modes and Processes
8.4 Valacyclovir API Sales and Marketing
8.4.1 Valacyclovir API Sales Channels
8.4.2 Valacyclovir API Distributors
8.5 Valacyclovir API Customer Analysis
9 Valacyclovir API Market Dynamics
9.1 Valacyclovir API Industry Trends
9.2 Valacyclovir API Market Drivers
9.3 Valacyclovir API Market Challenges
9.4 Valacyclovir API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 78
USD 4250.00
(Single User License)
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 132
USD 4900.00
(Single User License)
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 96
USD 3950.00
(Single User License)
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
Valaciclovir(CAS:124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 135
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 78
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 132
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 96
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 92
Valaciclovir(CAS:124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published: 2024-02-07
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now